ResearcherTaipei Medical UniversityNo recent work listed
Chao-Di Chang
Matched on ORCID iD 0000-0002-1926-8344; OpenAlex author ID A5005159025. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 2
- In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Co-author DOI 10.1080/14756366.2023.2166039↗
- Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Co-author DOI 10.1186/s13148-019-0681-6↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiow‐Lin Pan · 2 shared papers, 2019–2023 · strength 0.26
- Paper In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. DOI 10.1080/14756366.2023.2166039↗
- Paper Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor b… DOI 10.1186/s13148-019-0681-6↗
- Min‐Wu Chao · 2 shared papers, 2019–2023 · strength 0.26
- Paper In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. DOI 10.1080/14756366.2023.2166039↗
- Paper Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor b… DOI 10.1186/s13148-019-0681-6↗
- Kai‐Cheng Hsu · 1 shared paper, 2023 · strength 0.17
- Li-Hsun Chang · 1 shared paper, 2019 · strength 0.10
- Che‐Ming Teng · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.